Sign In
Learn bits
Science & Tech.
Komal gupta

24/02/22 13:20 PM IST

Source: PIB

CORBEVAX

In News

CORBEVAXTM is India’s first indigenously developed receptor binding domain protein sub-unit vaccine for COVID-19.

About the Vaccine:

  • This is developed by Biological E Limited with the support of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC). 
  • It is a recombinant protein vaccine which uses the receptor binding domain of the spike protein on the viral surface. 
  • It is a double dose vaccine that is administered intramuscularly and stored at 2° C to 8° C.

More Related Current Affairs View All

28 Aug

IADT-1

'Recently, the Indian Space Research Organisation (ISRO) successfully carried out its first Integrated Air Drop Test (IADT-1), a crucial milestone in the preparation for the countr

Read More

28 Aug

H-1B visa changes

'H-1B visa changes 2025: United States Commerce Secretary Howard Lutnick called the popular H-1B visa program a “scam”, saying that American businesses should be focuse

Read More

28 Aug

UGC’s Learning Outcomes-based Curriculum Framework

'Recently, the University Grants Commission (UGC) issued a public notice on its development of a draft Learning Outcomes-based Curriculum Framework (LOCF).' LOCF is intended to

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps